Cytel Inc.

JCAs are changing how indirect comparative evidence must be generated and defended, and direct head-to-head data may not always be available or sufficiently aligned. MAICs can help address some of these evidence gaps — we discuss what makes them credible.  hubs.ly/Q04CJXX20

In just one week, Cytel will be at the 2026 Bay Area Biotech-Pharma Statistics Workshop in Foster City!

Book a meeting with a member of our team at BBSW here: hubs.ly/Q04CBHdq0

See you in Foster City! 👋

While RCTs remain the cornerstone of regulatory and HTA decision-making, advances in computational science are creating entirely new forms of evidence. Dalia Dawoud discuses two of the most promising developments: in-silico data & MIDD. Learn more:
hubs.ly/Q04CsXK00

Cytel will be at PHUSE EU Connect 2026 in Glasgow!

📍 Stop by Booth 8 to speak with the Cytel team.

See our upcoming presentations and book a meeting with a member of our team at PHUSE EU here: hubs.ly/Q04Crs7v0

See you in Glasgow! 👋

Independent physician review is the cornerstone of endpoint adjudication, but much of an Endpoint Adjudication Committee's efficiency and effectiveness is determined long before before a physician ever opens a case. Learn more: hubs.ly/Q04C3D8l0